1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > NRT Smoking Cessation Aids in Japan

NRT Smoking Cessation Aids in Japan

  • November 2016
  • -
  • Euromonitor International
  • -
  • 24 pages

Thanks to increasing health awareness, the number of smokers in Japan continued to decline in 2016. According to research from the leading tobacco manufacturer, Japan Tobacco, in May 2016, male smoking prevalence fell to below 30% for the first time in 40 years, down 0.6 percentage points on the previous year. Many consumers are finding healthier ways to deal with stress, such as through jogging or yoga. Moreover, more male consumers have become more conscious about their appearance, with smokin...

Euromonitor International’s NRT Smoking Cessation Aids in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

NRT Smoking Cessation Aids in Japan
NRT SMOKING CESSATION AIDS IN JAPAN
Euromonitor International
November 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2011-2016
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016
Table 4 Sales of NRT Gum by Flavour: % Value 2011-2016
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2012-2016
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2013-2016
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 1 Takeda Pharmaceutical Co Ltd: Key Facts
Summary 2 Takeda Pharmaceutical Co Ltd: Operational Indicators
Competitive Positioning
Summary 3 Takeda Pharmaceutical Co Ltd: Competitive Position 2016
Executive Summary
Consumer Health Industry Benefits From the Growing Self-medication Trend
Sales Also Boosted by Demand From Inbound Tourists
Competitive Environment Remains Fragmented
Drugstores/parapharmacies Gain Share
Further Positive Growth Expected Over the Forecast Period
Key Trends and Developments
Self-medication Continues To Increase
Channels
Inbound Tourism Boosts Demand
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 10 Life Expectancy at Birth 2011-2016
Market Data
Table 11 Sales of Consumer Health by Category: Value 2011-2016
Table 12 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 13 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 14 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format: % Value 2011-2016
Table 17 Distribution of Consumer Health by Format and Category: % Value 2016
Table 18 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 4 OTC: Switches 2014-2016
Sources
Summary 5 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Sleeping Aids Market: By Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking) Product (Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices) Medication (Prescription Based, OTC drugs, Herbal Drugs)-Forecast (2

Sleeping Aids Market: By Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking) Product (Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices) Medication (Prescription Based, OTC drugs, Herbal Drugs)-Forecast (2

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sleep aids are pills and medical devices that enable a person suffering from sleep disorder to fall asleep. Sleep aids consist of various products such as medications, sleep laboratories, sleep apnea devices, ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Europe Over-the-Counter (OTC) Drugs Market   Growth, Trends, and Forecasts (2016 - 2021)

Europe Over-the-Counter (OTC) Drugs Market Growth, Trends, and Forecasts (2016 - 2021)

  • $ 3850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The European market for over-the-counter (OTC) drugs is estimated to be USD 45.56 billion in the year 2014 and is expected to reach USD 55.75 billion by the end of the year 2019. During this period, the ...

Consumer Health In Poland

September 2016 $ 2423

Consumer Health In China

September 2016 $ 2423

Download Unlimited Documents from Trusted Public Sources

OTC Markets in Australia

  • November 2016
    4 pages
  • Vitamin  

  • Australia  

    Oceania  

    China  

View report >

OTC Industry in the UK

  • November 2016
    12 pages
  • United Kingdom  

View report >

OTC Markets in North America - Forecast

  • November 2016
    2 pages
  • Yogurt  

    Dietary Supplem...  

  • North America  

    World  

View report >

Related Market Segments :

OTC
Smoking Cessation

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.